Simone Detre

5.9k total citations · 1 hit paper
63 papers, 4.2k citations indexed

About

Simone Detre is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Simone Detre has authored 63 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 32 papers in Genetics and 26 papers in Cancer Research. Recurrent topics in Simone Detre's work include Estrogen and related hormone effects (30 papers), HER2/EGFR in Cancer Research (27 papers) and Breast Cancer Treatment Studies (22 papers). Simone Detre is often cited by papers focused on Estrogen and related hormone effects (30 papers), HER2/EGFR in Cancer Research (27 papers) and Breast Cancer Treatment Studies (22 papers). Simone Detre collaborates with scholars based in United Kingdom, United States and Switzerland. Simone Detre's co-authors include Mitch Dowsett, Janine Salter, Ian E. Smith, Margaret Hills, Roger A’Hern, Anthony Skene, Geraldine Walsh, Stephen Johnston, J. Michael Dixon and M Dowsett and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Simone Detre

61 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas.

1995 693 citations Simone Detre, Mitch Dowsett et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simone Detre United Kingdom	30	2.2k	1.7k	1.6k	1.3k	683	63	4.2k
Els M.J.J. Berns Netherlands	40	2.4k 1.1×	2.3k 1.4×	3.9k 2.4×	1.1k 0.9×	671 1.0×	87	6.3k
Junichi Kurebayashi Japan	37	1.9k 0.8×	999 0.6×	1.8k 1.1×	734 0.5×	425 0.6×	157	3.8k
Danila Coradini Italy	32	2.2k 1.0×	1.4k 0.8×	1.9k 1.2×	620 0.5×	333 0.5×	108	3.9k
Karen Chew United States	37	1.9k 0.9×	2.0k 1.1×	2.1k 1.3×	931 0.7×	726 1.1×	76	4.8k
Ellen Rawlinson Canada	12	2.8k 1.2×	2.4k 1.4×	1.6k 1.0×	474 0.4×	959 1.4×	16	4.9k
Anna Tsimelzon United States	33	2.6k 1.2×	2.1k 1.2×	2.7k 1.7×	882 0.7×	799 1.2×	62	5.1k
Olle Stål Sweden	49	3.9k 1.7×	2.6k 1.5×	3.4k 2.1×	2.0k 1.5×	1.2k 1.8×	183	7.5k
Hans Neubauer Germany	36	2.3k 1.0×	1.3k 0.8×	1.7k 1.1×	653 0.5×	386 0.6×	116	4.4k
Gen‐Hong Di China	34	1.6k 0.7×	1.6k 0.9×	1.6k 1.0×	500 0.4×	417 0.6×	121	3.6k
Vessela N. Kristensen Norway	37	1.4k 0.6×	2.3k 1.3×	3.2k 2.0×	806 0.6×	644 0.9×	132	5.1k

Countries citing papers authored by Simone Detre

Since Specialization

Citations

This map shows the geographic impact of Simone Detre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Detre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Detre more than expected).

Fields of papers citing papers by Simone Detre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone Detre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Detre. The network helps show where Simone Detre may publish in the future.

Co-authorship network of co-authors of Simone Detre

This figure shows the co-authorship network connecting the top 25 collaborators of Simone Detre. A scholar is included among the top collaborators of Simone Detre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone Detre. Simone Detre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

López‐Knowles, Elena, Simone Detre, Margaret Hills, et al.. (2022). Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study. Breast Cancer Research. 24(1). 61–61. 5 indexed citations

Woolf, David, Sonia P. Li, Simone Detre, et al.. (2019). Assessment of the Spatial Heterogeneity of Breast Cancers: Associations Between Computed Tomography and Immunohistochemistry. SHILAP Revista de lepidopterología. 11. 1179299X19851513–1179299X19851513. 4 indexed citations

López‐Knowles, Elena, Qiong Gao, Maggie C.U. Cheang, et al.. (2016). Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas. Breast Cancer Research. 18(1). 39–39. 20 indexed citations

Brentnall, Adam R., Jack Cuzick, Helen Byers, et al.. (2016). Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials. Breast Cancer Research and Treatment. 158(3). 591–596. 6 indexed citations

Sheri, Amna, Ian E. Smith, Stephen Johnston, et al.. (2014). Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy. Annals of Oncology. 26(1). 75–80. 78 indexed citations

Ghazoui, Zara, Francesca M. Buffa, Anita K. Dunbier, et al.. (2011). Close and Stable Relationship between Proliferation and a Hypoxia Metagene in Aromatase Inhibitor–Treated ER-Positive Breast Cancer. Clinical Cancer Research. 17(9). 3005–3012. 26 indexed citations

Ghazoui, Zara, Francesca M. Buffa, Anita K. Dunbier, et al.. (2011). Close and Stable Relationship between Proliferation and a Hypoxia Metagene in Aromatase Inhibitor-Treated ER-Positive Breast Cancer (vol 17, pg 3005, 2011). Clinical Cancer Research. 17. 4915–4915. 1 indexed citations

Banerjee, Susana, Roger A’Hern, Simone Detre, et al.. (2010). Biological Evidence for Dual Antiangiogenic-Antiaromatase Activity of the VEGFR Inhibitor PTK787/ZK222584 In vivo. Clinical Cancer Research. 16(16). 4178–4187. 14 indexed citations

Léary, Alexandra, Suzanne Drury, Simone Detre, et al.. (2010). Lapatinib Restores Hormone Sensitivity with Differential Effects on Estrogen Receptor Signaling in Cell Models of Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer with Acquired Endocrine Resistance. Clinical Cancer Research. 16(5). 1486–1497. 70 indexed citations

10.

MacNeill, Fiona, Janine Salter, Simone Detre, et al.. (2010). Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer. Breast Cancer Research. 12(5). R76–R76. 103 indexed citations

11.

Martin, Lesley‐Ann, Julia E. Head, Sunil Pancholi, et al.. (2007). The farnesyltransferase inhibitor R115777 (tipifarnib) in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progression in vitro and in vivo. Molecular Cancer Therapeutics. 6(9). 2458–2467. 37 indexed citations

12.

Smith, Ian E., Geraldine Walsh, Anthony Skene, et al.. (2007). A Phase II Placebo-Controlled Trial of Neoadjuvant Anastrozole Alone or With Gefitinib in Early Breast Cancer. Journal of Clinical Oncology. 25(25). 3816–3822. 169 indexed citations

13.

Dowsett, Mitch, Ian E. Smith, S. Ebbs, et al.. (2007). Prognostic Value of Ki67 Expression After Short-Term Presurgical Endocrine Therapy for Primary Breast Cancer. JNCI Journal of the National Cancer Institute. 99(2). 167–170. 469 indexed citations

14.

Dowsett, Mitch, J. Michael Dixon, Anthony Skene, et al.. (2005). Biomarker Changes During Neoadjuvant Anastrozole, Tamoxifen, or the Combination: Influence of Hormonal Status and HER-2 in Breast Cancer—A Study from the IMPACT Trialists. Journal of Clinical Oncology. 23(11). 2477–2492. 229 indexed citations

15.

Johnston, Stephen, Julia E. Head, Sunil Pancholi, et al.. (2003). Integration of Signal Transduction Inhibitors with Endocrine Therapy. Clinical Cancer Research. 9(1). 3 indexed citations

16.

Detre, Simone, M.G. Ormerod, Jenny Titley, & Mitch Dowsett. (1997). An unusual artefact in the terminal deoxynucleotidyl transferase assay for apoptotic cells. Cytometry. 28(3). 264–267. 3 indexed citations

17.

Dowsett, Mitch, Andreas Makris, Peter Ellis, et al.. (1996). Oncogene Products and Other Diagnostic Markers in Human Breast Cancer Patients. Annals of the New York Academy of Sciences. 784(1). 403–411. 4 indexed citations

18.

Dowsett, Mitch, et al.. (1996). The control and biological importance of intratumoural aromatase in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 56(1-6). 145–150. 25 indexed citations

19.

Macaulay, Valentine M., et al.. (1995). An in vivo model of intratumoural aromatase using aromatase‐transfected MCF7 human breast cancer cells. International Journal of Cancer. 62(3). 297–302. 21 indexed citations

20.

Thorpe, P E, Simone Detre, Donald W. Mason, A.J. Cumber, & W. C. J. Ross. (1983). Monoclonal Antibody Therapy: “Model” Experiments with Toxin-Conjugated Antibodies in Mice and Rats. Hämatologie und Bluttransfusion. 28. 107–111. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact